Grounded in science and built for real-world complexity, Integrated DNA Technologies (IDT) has partnered with researchers for nearly 40 years across the genomics workflow. Through consistent quality, trusted expertise, and flexible customization, we help scientists solve complex challenges, streamline workflows, and accelerate discoveries from insight to real-world impact.
Our broad portfolio of innovative genomic solutions helps lower barriers to discovery with the precision, speed, and reliability researchers need to move breakthroughs forward with confidence. Supporting applications across the genomics workflow, our solutions include:
• Next Generation Sequencing (including Archer™ and xGen™ solutions)
• Gene Regulation
• Primers & Probes
• CRISPR Gene Editing
• Gene Synthesis & Gene Fragments
• Custom Oligos
• Contract Manufacturing Services, including the world's first mRNA-based personalized CRISPR gene-editing drug product used to treat an infant with urea cycle disorder (UCD).
Together, these solutions empower researchers to unlock complexity, generate actionable insights, and accelerate the discoveries that improve human health and the world around us.
Through our resilient, vertically integrated global supply chain, we deliver reliable, customized solutions that help researchers overcome complexity, generate actionable insights, and simplify workflows at scale—enabling what was previously considered impossible.
We are proud to be part of Danaher (NYSE: DHR). Through Danaher's uniquely broad ecosystem of technologies, expertise, and capabilities, we collaborate closely with customers to solve their toughest challenges and move from idea to impact with greater speed, precision, and certainty. Powered by the rigor of the Danaher Business System and a culture of continuous improvement, we make time a competitive advantage for our customers and help unlock the transformative potential of science and technology to improve billions of lives every day.